Humalog is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Dispensing Solutions, Inc.. The primary component is Insulin Lispro.
| Product ID | 55045-3602_0b67b87e-09b2-4469-846e-52ea3f962018 |
| NDC | 55045-3602 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Humalog |
| Generic Name | Insulin Lispro |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 1996-07-24 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020563 |
| Labeler Name | Dispensing Solutions, Inc. |
| Substance Name | INSULIN LISPRO |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 1996-07-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020563 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1996-07-24 |
| Inactivation Date | 2019-11-13 |
| Ingredient | Strength |
|---|---|
| INSULIN LISPRO | 100 [iU]/mL |
| SPL SET ID: | c5f75765-86b8-4926-b8c3-b42133ca7ac8 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0002-7510 | Humalog | Insulin lispro |
| 0002-7511 | Humalog | Insulin lispro |
| 0002-7512 | Humalog | Insulin lispro |
| 0002-7516 | Humalog | Insulin lispro |
| 0002-7712 | Humalog | Insulin lispro |
| 0002-7714 | Humalog | Insulin lispro |
| 70518-1388 | Humalog | Humalog |
| 50090-1375 | Humalog | Humalog |
| 55045-3602 | Humalog | Humalog |
| 50090-4488 | Humalog | Humalog |
| 70518-2264 | Humalog | Humalog |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() HUMALOG 74314093 1963572 Live/Registered |
Eli Lilly and Company 1992-09-15 |